Agilent and Picometrics Ink Deal to Provide Tools for Biopharmaceutical Characterization | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent said today that it has signed a co-marketing agreement with Picometrics Technologies to provide combined solutions for capillary electrophoresis, laser induced fluorescence detection, and mass spectrometry for biopharmaceutical applications.

The platform is intended for the research and development of complex large-molecule biopharmaceutical compounds, and is the only online CE-LIF-MS solution currently available, Agilent said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."